These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1655130)

  • 21. Effect of ketoconazole on metabolism and binding of 1,25-dihydroxyvitamin D-3 by intact rat osteogenic sarcoma cells.
    Pols HA; Schilte HP; Visser TJ; Birkenhager JC
    Biochim Biophys Acta; 1987 Nov; 931(2):115-9. PubMed ID: 2822140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of vitamin D 24-hydroxylase messenger RNA and activity by 22-oxacalcitriol in mouse kidney and duodenum. Possible role in decrease of plasma 1 alpha,25-dihydroxyvitamin D3.
    Akeno N; Saikatsu S; Kimura S; Horiuchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2081-90. PubMed ID: 7802698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of 25-hydroxyvitamin D3-24-hydroxylase activity in Caco-2 cells. An in vitro model of intestinal vitamin D catabolism.
    Tomon M; Tenenhouse HS; Jones G
    Endocrinology; 1990 Jun; 126(6):2868-75. PubMed ID: 2351099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S; Li XY; Duell EA; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
    Pols HA; Birkenhäger JC; Schilte JP; Visser TJ
    Biochim Biophys Acta; 1988 Jun; 970(2):122-9. PubMed ID: 2838094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
    van Leeuwen JP; Birkenhäger JC; van den Bemd GJ; Buurman CJ; Staal A; Bos MP; Pols HA
    J Biol Chem; 1992 Jun; 267(18):12562-9. PubMed ID: 1320001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variant form of the 1,25-dihydroxyvitamin D3 receptor with low apparent hormone affinity in cultured monkey kidney cells (LLC-MK2). A model for tissue resistance to vitamin D.
    Kelly MA; Marion SL; Donaldson CA; Pike JW; Haussler MR
    J Biol Chem; 1985 Feb; 260(3):1545-9. PubMed ID: 2981861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
    Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
    J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo.
    Binderup L; Bramm E
    Biochem Pharmacol; 1988 Mar; 37(5):889-95. PubMed ID: 2830885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the X-linked Hyp mutation and vitamin D status on induction of renal 25-hydroxyvitamin D3-24-hydroxylase.
    Tenenhouse HS; Jones G
    Endocrinology; 1987 Feb; 120(2):609-16. PubMed ID: 3803293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcium regulating activity of 24a-homo-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-dimethyl-24,24-difluoro-1 alpha,25-dihydroxyvitamin D3.
    Harada M; Miyahara T; Miyata M; Komiyama H; Sugure A; Ikemoto Y; Kondo S; Takamura T; Higuchi S; Otomo S
    Calcif Tissue Int; 1993 Nov; 53(5):318-23. PubMed ID: 8287319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
    Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
    Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells.
    van Leeuwen JP; Pols HA; Schilte JP; Visser TJ; Birkenhäger JC
    Calcif Tissue Int; 1991 Jul; 49(1):35-42. PubMed ID: 1654178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
    Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
    J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of 26,27-hexafluoro-1 alpha,25-dihydroxyvitamin D3 and 26,27-hexafluoro-1 alpha,23(S)25-trihydroxyvitamin D3 in ROS17/2.8 cells transfected with a plasmid expressing CYP24.
    Miyahara T; Gomyo S; Ueda Y; Ohyama Y; Sigeno C; Kozakai A; Takamura T; Yamazaki R; Higuchi S; Yamamoto M; Sakuma T; Nemoto N
    Xenobiotica; 2000 Nov; 30(11):1055-62. PubMed ID: 11197067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells.
    Zhao X; Feldman D
    Endocrinology; 1993 Apr; 132(4):1808-14. PubMed ID: 8384998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.